Analytical Data
-
Gene name
PDCD5
- Application
-
Alternative Names
TF-1 cell apoptosis-related protein 19
-
Species
Human
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O14737
-
Expression Region
1-125aa
-
Molecular Weight
41.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PDCD5 (Programmed Cell Death 5) is a protein that has gained attention in the field of cancer research and apoptosis (programmed cell death) due to its role in regulating cell survival and death mechanisms. Originally identified as a pro-apoptotic factor, PDCD5 is linked to various cellular functions, including stress response and cell cycle regulation. Research has demonstrated that PDCD5 can enhance apoptosis under certain conditions, particularly in cancer cells, which often evade programmed cell death. Given its potential as a therapeutic target, scientists are investigating the recombinant expression of PDCD5 to better understand its molecular mechanisms and functional roles. By producing PDCD5 in a recombinant form, researchers aim to study its interactions with other proteins and signaling pathways involved in cell death, as well as its potential to augment the effectiveness of existing cancer therapies. Understanding how PDCD5 modulates apoptosis in different contexts can provide insights into developing novel cancer treatments, particularly for tumors that exhibit resistance to conventional therapies. Moreover, the exploration of PDCD5’s role in other diseases characterized by dysregulated apoptosis further underscores its significance in biomedical research. Overall, the study of PDCD5 recombinant protein presents a promising avenue for elucidating the complexities of apoptotic processes and improving cancer treatment strategies.
